Our collaboration partner Axcelead Drug Discovery Partners, Inc. offers high quality screening services using Nanion's Instruments
Axcelead Drug Discovery Partners, Inc. will combine scientific excellence, world-class IP protection and state-of-the art GLP accredited facilities and capabilities to deliver integrated end-to-end early discovery.
Axcelead is Japan's first provider of integrated drug discovery services - a one stop-shop for Research providing:
- Axcelead uses the SyncroPatch 384PE and offers high throughput ion channel screening.
- Axcelead is the first comprehensive integrated drug discovery solutions provider in the pharmaceutical industry in Japan, having succeeded some portion of the drug discovery research department of Takeda Pharmaceutical Company Limited. and started its business in July 1, 2017.
- Axcelead has all the functions related to non-clinical drug discovery research and are also able to draw on the scientific powerhouse of our personnel with expertise, deep knowledge and experience in a range of therapeutic areas through their work at Takeda.
- Axcelead will offer a one stop-shop research services with a comprehensive set of best-in-class capabilities to meet a range of customer needs to bridge basic and applied clinical research, from exploratory research to optimizing compounds.
Axcelead Drug Discovery Partners fully supports your drug discovery research in all stages not only from target identification to candidate selection but also bridging to Investigational New Drug(IND)/New Drug Application(NDA).